February 29th - $ENTHEON BIOMEDICAL CORP (ENTBF.US)$ is about to implement a 1-for-10 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from March 1st, 2024.
$ENTHEON BIOMEDICAL CORP (ENTBF.US)$ closed at $0.0086 on February 28th . $ENTHEON BIOMEDICAL CORP (ENTBF.US)$ now has a total market capitalization of $508.16K.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.